Glaucoma ignorance highlighted

Article

On World Sight Day, Windows to Health, the Pfizer UK initiative to promote regular eye test attendance, unveiled results of the All Eyes on Glaucoma survey, which highlighted the UK's ignorance around glaucoma and its prevention.

On World Sight Day, Windows to Health, the Pfizer UK initiative to promote regular eye test attendance, unveiled results of the All Eyes on Glaucoma survey, which highlighted the UK's ignorance around glaucoma and its prevention.

The survey, of UK adults aged ≥16 years (n=2297), demonstrated low levels of glaucoma awareness and attempts at disease prevention. The respondents reported poor rates of attendance at optician appointments; <50% had visited an optician in the last five years; approximately 20% will visit an optician only when a specific vision problem becomes apparent, and the same percentage is unclear as to the availability of (and their own eligibility for) free eye tests. Approximately one third of respondents were unaware of the symptoms of glaucoma, which may explain why an estimated half a million people in England and Wales suffer from the disease yet remain undiagnosed.

World Sight Day is an annual day of events to promote awareness of low vision and blindness. Although events are organized independently, the World Sight Day initiative - held on the second Thursday in October - is co-ordinated by the International Agency for the Prevention of Blindness (IAPB) and organized by VISION 2020, the campaign to eliminate preventable blindness by 2020.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.